Seung Won

2.4k total citations · 1 hit paper
93 papers, 1.4k citations indexed

About

Seung Won is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Seung Won has authored 93 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 17 papers in Epidemiology. Recurrent topics in Seung Won's work include Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers), Asthma and respiratory diseases (23 papers) and Respiratory Support and Mechanisms (16 papers). Seung Won is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers), Asthma and respiratory diseases (23 papers) and Respiratory Support and Mechanisms (16 papers). Seung Won collaborates with scholars based in South Korea, United States and Canada. Seung Won's co-authors include Ok‐Joo Sul, Soohyun Bae, Jiwon Jung, Sung‐Han Kim, Ji-Hoon Lee, Mi-Jung Kim, Yeon‐Mok Oh, Tae‐Hyung Kim, Joon Beom Seo and Sang‐Do Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Seung Won

84 papers receiving 1.4k citations

Hit Papers

Quercetin Prevents LPS-Induced Oxidative Stress and Infla... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seung Won South Korea 17 615 242 232 199 174 93 1.4k
Jian Luo China 22 615 1.0× 267 1.1× 148 0.6× 280 1.4× 273 1.6× 108 1.7k
Antoine Guillon France 24 470 0.8× 156 0.6× 302 1.3× 413 2.1× 317 1.8× 101 1.7k
Antonia Koutsoukou Greece 25 1.0k 1.7× 279 1.2× 449 1.9× 366 1.8× 269 1.5× 102 2.1k
Ka Pang Chan Hong Kong 17 440 0.7× 294 1.2× 408 1.8× 252 1.3× 168 1.0× 61 1.3k
Guillaume Voiriot France 23 612 1.0× 98 0.4× 423 1.8× 656 3.3× 233 1.3× 132 2.0k
Kristina L. Bailey United States 23 426 0.7× 177 0.7× 144 0.6× 154 0.8× 226 1.3× 76 1.3k
Walter K. Kraft United States 29 243 0.4× 329 1.4× 283 1.2× 394 2.0× 213 1.2× 128 2.5k
Manoj J. Mammen United States 16 342 0.6× 143 0.6× 204 0.9× 150 0.8× 211 1.2× 37 1.0k
Wu-Huei Hsu Taiwan 28 1.1k 1.7× 195 0.8× 223 1.0× 217 1.1× 259 1.5× 93 2.0k
Juan Fu China 25 665 1.1× 768 3.2× 188 0.8× 179 0.9× 341 2.0× 106 2.0k

Countries citing papers authored by Seung Won

Since Specialization
Citations

This map shows the geographic impact of Seung Won's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung Won with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung Won more than expected).

Fields of papers citing papers by Seung Won

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung Won. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung Won. The network helps show where Seung Won may publish in the future.

Co-authorship network of co-authors of Seung Won

This figure shows the co-authorship network connecting the top 25 collaborators of Seung Won. A scholar is included among the top collaborators of Seung Won based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seung Won. Seung Won is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Won, Seung, Seoung Ju Park, Soo‐Jung Um, et al.. (2025). Clinical Outcomes in Patients With COPD With Disease Stability. CHEST Journal.
3.
Lee, Hyun, Hayoung Choi, Seung Won, et al.. (2025). Bronchodilator response as an independent predictor of severity in bronchiectasis. Journal of Thoracic Disease. 17(10). 7515–7527.
4.
Kim, Tae Hoon, Joo Hun Park, Hee‐Young Yoon, et al.. (2024). Factors Associated with the Discrepancy between Exercise Capacity and Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease. Tuberculosis & respiratory diseases. 87(2). 155–164. 1 indexed citations
5.
Moon, Ji‐Yong, Sang Hyuk Kim, Youlim Kim, et al.. (2024). Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea. Pulmonary Pharmacology & Therapeutics. 85. 102298–102298. 3 indexed citations
6.
Won, Seung, et al.. (2023). Lifestyle practices that reduce seasonal PM2.5 exposure and their impact on COPD. Scientific Reports. 13(1). 11822–11822. 3 indexed citations
7.
Choi, Joon Young, Chin Kook Rhee, Kwang Ha Yoo, et al.. (2023). Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD. Therapeutic Advances in Respiratory Disease. 17. 2683748800–2683748800. 5 indexed citations
8.
Sul, Ok‐Joo, et al.. (2023). GSPE attenuates CSE-induced lung inflammation and emphysema by regulating autophagy via the reactive oxygen species/TFEB signaling pathway. Food and Chemical Toxicology. 177. 113795–113795. 9 indexed citations
9.
Ock, Minsu, Ji Soo Shin, & Seung Won. (2022). Safety and Effectiveness of Varenicline in Korean Smokers: A Nationwide Post-Marketing Surveillance Study. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Choi, Hayoung, Hye Yun Park, Juhwan Yoo, et al.. (2022). Non–Cystic Fibrosis Bronchiectasis Increases the Risk of Lung Cancer Independent of Smoking Status. Annals of the American Thoracic Society. 19(9). 1551–1560. 28 indexed citations
11.
Lee, Hyun Woo, Jung‐Kyu Lee, Myung Goo Lee, et al.. (2022). Risk Factors of Rapid FEV<sub>1</sub> Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort. Respiration. 101(12). 1078–1087. 9 indexed citations
12.
Won, Seung, et al.. (2021). The impact of life behavior and environment on particulate matter in chronic obstructive pulmonary disease. Environmental Research. 198. 111265–111265. 11 indexed citations
13.
Kim, Taehee, Hyun Lee, Yun Su Sim, et al.. (2021). Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study. Journal of Thoracic Disease. 13(8). 4894–4902. 7 indexed citations
14.
Choi, Hayoung, Bumhee Yang, Yong Suk Jo, et al.. (2021). Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities. Scientific Reports. 11(1). 7126–7126. 43 indexed citations
16.
Jo, Yong Suk, Sun Hye Shin, Hyeon‐Kyoung Koo, et al.. (2019). Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids. Tuberculosis & respiratory diseases. 83(1). 42–42. 8 indexed citations
17.
Lee, Jung‐Kyu, Chin Kook Rhee, Kyungjoo Kim, et al.. (2019). <p>Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease</p>. International Journal of COPD. Volume 14. 2639–2647. 4 indexed citations
18.
Park, Hye Yun, Suh‐Young Lee, Danbee Kang, et al.. (2018). Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort. Respiratory Research. 19(1). 36–36. 25 indexed citations
19.
Won, Seung, Yong Soo Kwon, Sung Ho Yoon, et al.. (2017). Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease. The Clinical Respiratory Journal. 12(4). 1424–1432. 7 indexed citations
20.
Filho, Fernando Sergio Leitão, Seung Won, André Mattman, et al.. (2017). Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 140(4). 1164–1167.e6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026